HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
Vatalanib
Description
Vatalanib (PTK787/ZK-222584) is a new oral antiangiogenic molecule that inhibits all known vascular endothelial growth factor receptors. Vatalanib is under investigation for the treatment of solid tumors.
No brand information found.
